We made our debut in the \u201cStock Exchange Company of the Year\u201d ranking a year ago. Yesterday, we once again stood on the podium, adding four more distinctions to our pool of awards. In the 27th edition of the Puls Biznesu ranking, we received the highest scores from analysts and fund managers in the \u201cGrowth Prospects\u201d category. We placed third in the \u201cHighest Innovation in Products and Services\u201d and \u201cInvestor Relations\u201d categories. In the overall ranking, we are once again in the TOP3.<\/p>\n
Pride and satisfaction!<\/p>\n
\u0141ukasz Bzdzion and Pawe\u0142 Wielgus emphasize:<\/p>\n
\ud83d\udcac The strength of Bioceltix lies in a team that knows where it is heading and is able to turn ambitious ideas into reality. A long time ago, we made the decision to take on the challenge of developing a veterinary medicinal product containing stem cells, which from the very beginning required an uncompromising approach to quality, the manufacturing process, and completing the full registration pathway. We are on the right track. We are paving new biotechnological paths and are pleased that the market appreciates it.<\/p>\n
\u201cBioceltix on the starting blocks for pharmaceutical millions,\u201d writes Puls Biznesu in today\u2019s article.<\/p>\n
Thank you for the distinctions, congratulations to the other leaders of the Polish market, and see you next year!<\/p>\n